Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy

Clinical Nephrology

Volumn 71, Issue 6, 2009, Pages 625-631

  Jiang, X Y ^a   Mo, Y ^a   Sun, L Z ^a   Yue, Z H ^a   Chen, S M ^a   Wu, W ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cyclophosphamide; Glomerulonephritis; Methylprednisolone; Pediatric IgA nephropathy; Renal biopsy; Renal insufficiency

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; METHYLPREDNISOLONE; PREDNISONE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ALBUMIN BLOOD LEVEL; ALOPECIA; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CUSHING SYNDROME; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE; FEMALE; FOLLOW UP; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MESANGIUM CELL; MYCOPLASMA PNEUMONIA; NAUSEA AND VOMITING; NEPHROSCLEROSIS; PRESCHOOL CHILD; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; SCHOOL CHILD; TREATMENT DURATION; BIOPSY; DRUG COMBINATION; DRUG EFFECT; DRUG PULSE THERAPY; KIDNEY; METHODOLOGY; PATHOLOGY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; BIOPSY; CHILD; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; METHYLPREDNISOLONE; PROTEINURIA; PULSE THERAPY, DRUG; TREATMENT OUTCOME;

EID: 67651031228     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71625     Document Type: Article

References (27)

1. Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr Nephrol. 1989; 3: 248-253.
2. Barratt J, Smith AC, Feehally J. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology. 2007; 12: 275-284.
3. Coppo R. Pediatric IgA nephropathy: clinical and therapeutic perspectives. Semin Nephrol. 2008; 28: 18-26.
4. Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol. 2000; 11: 2395-2403.
5. Fofi C, Pecci G, Galliani M et al. IgA nephropathy: multivariate statistical analysis aimed at predicting outcome. J Nephrol. 2001; 14: 280-285.
6. Haas M, Rahman MH, Cohn RA et al. IgA Nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant. 2008; 23: 2537-2545.
7. Hogg RJ, Lee J, Nardelli N et al. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group. Clin J Am Soc Nephrol. 2006; 1: 467-474.
8. Hotta O, Furuta T, Chiba S et al. Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis. 2002; 39: 493-502.
9. Ikezumi Y, Suzuki T, Imai N et al. Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant. 2006; 21: 3466-3474.
10. Jiang XY. Subspecialty Group of Nephrology, Society of Pediatrics, Chinese Medical Association. Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals. Chinese journal of pediatrics. 2007; 45: 272-278. (Article in Chinese)
11. Katafuchi R, Ninomiya T, Mizumasa T et al. The improvement of renal survival with steroid pulse therapy in IgA nephropathy. Nephrol Dial Transplant. 2008; 23: 3915-3920.
12. Lau KK, Wyatt RJ, Moldoveanu Z et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol. 2007; 22: 2067-2072.
13. Lee HS, Lee MS, Lee SM et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant. 2005; 20: 342-348.
14. Lee SM, Rao VM, Franklin WA et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982; 13: 314-322.
15. Mitsuiki K, Harada A, Okura T et al. Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide. Clin Exp Nephrol. 2007; 11: 297-303.
16. Narita I, Gejyo F. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy. Clin Exp Nephrol. 2008; 12: 332-338.
17. Pozzi C, Bolasco PG, Fogazzi GB et al. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet. 1999; 353: 883-887.
18. Rasche FM, Klotz CH, Czock D et al. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy. Nephron Clin Pract. 2002; 93: 131-136.
19. Rasche FM, Klotz CH, Czock D et al. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy. Nephron Clin Pract. 2003; 93: c131-c136.
20. Roccatello D, Ferro M, Coppo R et al. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy. Nephrol Dial Transplant. 1995; 10: 2054-2059.
21. Roccatello D, Ferro M, Cesano G et al. Steroid and cyclophosphamide in IgA nephropathy. Nephrol Dial Transplant. 2000; 15: 833-835.
22. Tumlin AJ, Lohavichan V, Hennigar R. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrol Dial Transplant. 2003; 18: 1321-1329.
23. Wyatt RJ, Kritchevsky SB, Woodford SY et al. IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr. 1995; 127: 913-919.
24. Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clin Nephrol 2006; 65: 227.
25. Yoshikawa N, Honda M, Iijima K et al. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol. 2006; 1: 511-517.
26. Yoshikawa N, Ito H, Sakai T et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol. 1999; 10: 101-109.
27. Zhou M, Ma J, Tao Y. Efficacy evaluation by repeat renal biopsies: integrated traditional Chinese and Western medicine treatment of children with IgA nephropathy. Chinese journal of integrated traditional and Western medicine. 2006; 16: 619-620.